Using univariate analysis to evaluate the overall effects of germline APOBEC3A/B deletion on APOBEC-mutational signature, we found that the deletion was significantly associated with increased APOBEC-mutational signature only in breast cancer (P = 5.6 × 10− 3; Table 3; Fig. 3a). This evidence concerns the gene APOBEC3A and breast carcinoma.